Diapositiva 1 - Universidad de Navarra
Download
Report
Transcript Diapositiva 1 - Universidad de Navarra
www.unav.es/preventiva
The PREDIMED trial
www.unav.es/preventiva
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
Evolution of designs
Evolution of exposure in nutritional epidemiology
evidence
of evidence
Quality of
Quality
High
High
Low
Low
Randomized Trial
Cohort
Nested case-control
Case-control
Ecological (cross-cultural, international comparisons)
Food patterns
Food grouping & indexes
Food items: olive oil, tomato, garlic, etc.
Micronutrients: antioxidants, vitamins, etc.
Single macronutrient: CHO, Types of Fat, Protein
DOG
www.unav.es/preventiva
Mediterranean Food pattern
Rapidly increasing evidence
Increased Longevity
Prevention of
CV mortality
Cancer mortality
CVD incidence
Metabolic syndrome
Diabetes
Dementia
Depression
Highly palatable!
Scarcity of large randomized trials
DOG
www.unav.es/preventiva
Mediterranean Food pattern
Rapidly increasing evidence
Increased Longevity
Prevention of
CV mortality
Cancer mortality
CVD incidence
Metabolic syndrome
Diabetes
Dementia
Depression
Highly palatable!
Scarcity of large randomized trials
DOG
www.unav.es/preventiva
de Lorgeril M, Salen P, Martin JL, et al. Final Report of
the Lyon Diet Heart Study. Circulation 1999;99:779-785.
DOG
www.unav.es/preventiva
Eur J Epidemiol
2004;19:9-13.
• What is the MeDiet?
•
•
•
•
Olive oil as the main added lipid
Unrestricted Total Fat
MUFA-rich diet in the intervention group
Low consumption of meat / meat products
• and what it is NOT the MeDiet
• Margarine, soybean oil, mustard oil...
DOG
de Lorgeril et al. Lyon trial. Circulation 1999;99:779-785.
Diet assessed in
~30% of control
~50% of experimental
No biochemical
confirmation of
adherence.
Trial stopped
after 27 months.
Low number of
observed endpoints
(14 vs. 44).
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
Funding agency
DOG
www.unav.es/preventiva
Funding History
2003 2004 2005 2006 2007 2008 2009
17
15
15
Initial Network
DOG
14
adhoc
grant
17
18
19
Network RD 06/0045
Consortium ciberobn
www.unav.es/preventiva
Centers
11 RECRUITMENT GROUPS
DOG
8 ONLY-LAB GROUPS
•
•
Navarra- MA Martinez-Gonzalez
Valencia- D Corella
•
•
Barcelona-1- E Ros
Sevilla- V Ruiz-Gutierrez
•
•
•
•
Reus- J Salas-Salvado
Mallorca- M Fiol
Sevilla- J Lapetra
Málaga- E Gomez-Gracia
•
•
•
•
•
Barcelona-1- R Estruch
Vitoria- F Aros
Barcelona-2- MI Covas
Las Palmas- L Serra-Majem
Barcelona-3- X Pinto
•
•
•
•
•
•
Barcelona-2- RM Lamuela-Raventos
Navarra- JA Martinez
Valencia- G Saez
Barcelona-3- MT Mitjavila
Mallorca- JA Tur
Vitoria- MP Portillo
www.unav.es/preventiva
Funded by network (RD 06/0045)
6 RECRUITMENT GROUPS
DOG
7 LAB-ONLY GROUPS
•
•
Navarra- MA Martinez-Gonzalez
Valencia- D Corella
•
•
Barcelona-1- E Ros
Sevilla- V Ruiz-Gutierrez
•
•
•
•
Reus- J Salas-Salvado
Mallorca- M Fiol
Sevilla- J Lapetra
Málaga- E Gomez-Gracia
•
•
•
•
•
Barcelona-1- R Estruch
Vitoria- F Aros
Barcelona-2- MI Covas
Las Palmas- L Serra-Majem
Barcelona-3- X Pinto
•
•
•
•
•
•
Barcelona-2- RM Lamuela-Raventos
Navarra- JA Martinez
Valencia- G Saez
Barcelona-3- MT Mitjavila
Mallorca- JA Tur
Vitoria- MP Portillo
www.unav.es/preventiva
Funded by consortium (ciberobn)
5 RECRUITMENT GROUPS
DOG
1 LAB-ONLY GROUP
•
•
Navarra- MA Martinez-Gonzalez
Valencia- D Corella
•
•
Barcelona-1- E Ros
Sevilla- V Ruiz-Gutierrez
•
•
•
•
Reus- J Salas-Salvado
Mallorca- M Fiol
Sevilla- J Lapetra
Málaga- E Gomez-Gracia
•
•
•
•
•
Barcelona-1- R Estruch
Vitoria- F Aros
Barcelona-2- MI Covas
Las Palmas- L Serra-Majem
Barcelona-3- X Pinto
•
•
•
•
•
•
Barcelona-2- RM Lamuela-Raventos
Navarra- JA Martinez
Valencia- G Saez
Barcelona-3- MT Mitjavila
Mallorca- JA Tur
Vitoria- MP Portillo
www.unav.es/preventiva
Food industry: only food items
DOG
Provision of Olive oil
Provision of nuts
~2 000 l/wk
30 kg/wk walnuts
15 kg/wk almonds
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
PREDIMED TRIAL: DESIGN
Men: 55-80 yr
Women: 60-80 yr
High CV risk without CVD
type 2 diabetics
3+ risk factors
Random
1. Smoking
2. Hypertension
3. LDL
4. HDL
5. Overweight/obes
6. Family history
www.unav.es/preventiva
PREDIMED Participants
11 RECRUITMENT GROUPS
•
Navarra- MA Martinez-Gonzalez
•
Valencia- D Corella
•
Reus- J Salas-Salvado
•
Mallorca- M Fiol
•
Málaga- E Gomez-Gracia
•
Barcelona-1- R Estruch
•
Sevilla- J Lapetra
•
Vitoria- F Aros
•
Barcelona-2- MI Covas
•
Las Palmas- L Serra-Majem
•
Barcelona-3- X Pinto
Navarra
Valencia
Reus
Mallorca
Málaga
Barcelona 1
Sevilla
Vitoria
Barcelona 2
Las Palmas
Barcelona 3
Total
DOG
n
~P-Y
1048
1049
870
594
540
667
659
641
570
356
238
5470
3830
3680
2460
2400
2400
2220
2210
2060
690
490
7232 27,910
www.unav.es/preventiva
Project Leader: Dr. Ramón Estruch
DOG
www.unav.es/preventiva
PREDIMED Participants
Mediet + VOO
(n= 2487)
MeDiet + Nuts
(n=2396)
Control
(n=2349)
67 (6)
67 (6)
67 (6)
Women (%)
57
54
58
Diabetes (%)
50
47
48
Hypertension (%)
82
82
84
Current smokers (%)
14
15
14
High cholest. (%)
72
73
72
30 (4)
30 (4)
30 (4)
100 (10)
100 (10)
101 (11)
8.7 (2)
8.7 (2)
8.3 (2)
Age (SD)
BMI (SD)
Waist (SD)
MeDiet 0-14 p (SD)
DOG
www.unav.es/preventiva
PREDIMED: primary end-point
Either:
cardiovascular death
myocardial infarction
stroke
DOG
www.unav.es/preventiva
PREDIMED: Secondary end-points
total mortality
heart failure
major cancers
diabetes
dementia
DOG
We will also ascertain
intermediate outcomes:
•blood pressure (BP)
•fasting blood glucose
•lipid profile
•markers of inflammation
•other markers of CVD
www.unav.es/preventiva
PREDIMED: intervention
Introduce changes in the overall food pattern
Mediterranean diet: 2 groups
Total Fat: ad libitum
High in
MUFA (virgin olive oil)
Fish
Fruits, vegetables, legumes
Low in meats & dairy
alcohol permitted: wine
Low-fat diet - Control
Reduce every fat
Increase CHO
No Energy limitation
DOG
tocopherols
polyphenols
flavonoids
phytosterols
www.unav.es/preventiva
Ann Intern Med 2006;145:1-11
Appendix, table 1 (on-line)
1.
2.
3.
4.
5.
6.
7.
DOG
Olive oil main culinary fat
Olive oil >=4 tablespoons/d
Vegs>=2 serv./d
Fruits>=3 serv./d
Red meats<1/d
Butter, marg, cream<1/d
Soda drinks<1/d
14-point score
8. Wine >=3 glasses/wk
9. Legumes >=3/wk
10. Fish & seafood >=3/wk
11. Cakes, sweets <3/wk
12. Nuts >=1/wk
13. Poultry > red meats
14. Sofrito
www.unav.es/preventiva
Strategies for behavior change
Repeated personal contacts: every 3-mo
Group sessions: every 3-mo
Holistic approach
Written information
Self-monitoring
Individualized goal-setting
Quick feedback
Individual motivational interviews (every 3-mo)
DOG
adapted to the patient’s features
clinical condition
preferences
beliefs
expressed in servings/d to improve understanding
www.unav.es/preventiva
Strategies for behavior change-2
Additional strategies
Seasonal buying lists
Menus and recipes
Only in the 2 MeDiet groups
Provision of key food items for free
DOG
www.unav.es/preventiva
Special emphasis
Negotiated goal setting
Contracted agreement
Understandable: units=servings
Options for the negotiation
Serving size
Frequency of consumption
Way of cooking
DOG
www.unav.es/preventiva
Group sessions
DOG
www.unav.es/preventiva
Projected follow-up = 6 years (median)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Recruitm.
% of
1Year
yr
recruitment
22003
yr
9
32004
yr
21
42005
yr
28
52006
yr
11
6 yr
Cum. %
9
30
58
69
2007
13
82
2008
17
99
2009
1
100
Total
DOG
100
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
3-mo changes
Ann Intern Med 2006;145:1-11
DOG
www.unav.es/preventiva
3-mo changes in RF
•772 participants (55-80 yr)
•Randomization:
•257 to a MeDiet + (free provision of olive oil)
•258 to a MeDiet + (free provision of nuts)
•257 to a LFD (control group)
•Follow-up: 3 months
•Nutrient profile and food items consumption
•Mediterranean score (14-point score)
•Classical risk factors
•Novel risk factors (CRP, IL6, VCAM, ICAM)
DOG
www.unav.es/preventiva
3-mo changes in RF
DOG
www.unav.es/preventiva
3-mo changes in diet
DOG
www.unav.es/preventiva
3-mo changes in Risk Factors
3
2
1
0
-1
-2
-3
-4
-5
-6
-7
MeDiet (+VOO)
p<0.001
p=0.048
p<0.001
p=0.001
CONTROL
p<0.001
p=0.006
SBP change
(mmHg)
DOG
MeDiet (+Nuts)
DBP change
(mm Hg)
LDL change
(mg/dl)
HDL change
(mg/dl)
www.unav.es/preventiva
3-mo changes in Risk Factors
8
6
4
2
0
-2
-4
-6
-8
-10
-12
MeDiet (+VOO)
p=0.022
TG change (mg/dl)
DOG
MeDiet (+Nuts)
CONTROL
p=0.017
p<0.001
p=0.039
p<0.001
Glucose change (mg/dl)
Insulin change (pmol/L)
www.unav.es/preventiva
3-mo changes in Risk Factors
0,4
0,2
0
MeDiet (+VOO)
MeDiet (+Nuts)
CONTROL
p<0.001
p<0.001
p=0.37
p=0.002
p<0.001
p=0.84
TC/HDL ratio (change)
HOMA index (change)
-0,2
-0,4
-0,6
-0,8
-1
DOG
Waist change (cm)
www.unav.es/preventiva
3-mo changes in Risk Factors
DOG
www.unav.es/preventiva
3-mo changes in Risk Factors
DOG
www.unav.es/preventiva
3-mo changes in Risk Factors
DOG
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
Salas-Salvado et al, Eur J Clin Nutr 2008;62:651-9
DOG
www.unav.es/preventiva
Salas-Salvado et al, Eur J Clin Nutr 2008;62:651-9
•339 men and 433 women (55-80 yr)
•Exposure:
•Food groups (137-item FFQ)
•MeDiet adherence (14-point score)
•Outcomes:
•hs-C Reactive protein
•interleukin-6 (IL-6)
•intracellular adhesion molecule-1 (ICAM-1)
•vascular cell adhesion molecule-1 (VCAM-1)
DOG
www.unav.es/preventiva
Salas-Salvado et al, Eur J Clin Nutr 2008;62:651-9
Change
(p value*)
CRP
IL6
Cereals
(0.005)
Fruits
(0.008)
VCAM1
(0.003)
Nuts
(0.02)
Virgin Olive Oil
MeDiet**
ICAM1
(0.14) (0.49)
(0.09)
(0.09)
*Adjusted for age, gender, diabetes, smoking, BMI, educational level, use of statins,
NSAID, and aspirin.
**Test for linear trend (multivariate adjusted)
DOG
www.unav.es/preventiva
Salas-Salvado et al, Eur J Clin Nutr 2008;62:651-9
1400
8
1200
VCAM-1
ICAM-1 7
IL-6 (pg/ml)
CRP (mg/l)
6
1000
ng/ml
5
800
4
3.59
600
3
400
3.51
2
200
1
0
0
<7
DOG
3.18
7 to 10
MeDiet score (0-14)
>10
<7
7 to 10
MeDiet score (0-14)
>10
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o
•
•
•
•
DOG
MeDiet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
Sánchez-Tainta, et al. Eur J Cardiovasc Prev Rehabil. 2008;15:589-93.
•3204 participants
•Exposure: MeDiet (14-point score)
•Adherence: Above Median (9) in the score
•Ordered categories (5) in the score
•Outcomes:
•Diabetes
•Hypertension
•Obesity
•Hypercholesterolemia
All of them
together
www.unav.es/preventiva
Adj. Prevalence OR (95% CI)
MeDiet (>Median) and prevalence of Risk Factors
1,2
Sánchez-Tainta, et al. Eur J Cardiovasc Prev Rehabil. 2008;15:589-93.
1
0,8
0,6
0,4
0,2
0
Hypertension
Diabetes
Obesity
Hypercholesterolemia
Adjusted for age, gender, leisure-time physical activity (tertiles), smoking (5 categories), marital status (4
categories), educational level (4 categories), and BMI (3 categories, except when using obesity as outcome).
DOG
www.unav.es/preventiva
Adherence to MeDiet and prevalence of diabetes
adj. OR (95% CI)
1,4
1,2
1
1 (ref.)
0.99
1.00
0,8
0.69
0,6
0.67
0,4
0,2
0
<=7 (n=802)
8 (n=547)
9 (n=570)
10 (n=507)
>=11 (n=778)
Mediterranean diet score (14 points)
Adjusted for age, gender, leisure-time physical activity (tertiles), smoking (5 categories), marital status (4
categories), educational level (4 categories), and BMI (3 categories).
DOG
www.unav.es/preventiva
Adherence to MeDiet & prevalence of all 4 RF
p<0.001 for linear trend
1,4
adj. OR (95% CI)
1,2
1
1 (ref.)
1.03
0,8
0.78
0.68
0,6
0,4
0,2
0
0.38
Sánchez-Tainta, et al. Eur J Cardiovasc Prev Rehabil. 2008;15:589-93.
<=7 (n=802)
8 (n=547)
9 (n=570)
10 (n=507)
>=11 (n=778)
Mediterranean diet score (14 points)
Adjusted for age, gender, leisure-time physical activity (tertiles), smoking (5 categories), marital status (4
categories), and educational level (4 categories).
DOG
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
Fitó for the PREDIMED group. Arch Inter Med 2007;167:1195-1203.
Mediet+VOO=123
n = 372
Mediet+nuts=128
control=121
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
1-yr changes in diet
Zazpe et al for the PREDIMED group,
J Am Diet Assoc 2008;108:1134-44
DOG
www.unav.es/preventiva
1-yr changes in diet
n= 1551 in 3 groups:
• MeDiet +VOO: 533
• MeDiet +Nuts: 533
• Control: 485
Assessment of changes from baseline
DOG
Baseline characteristics of the 3 randomized groups
Baseline characteristics of the 3 randomized groups
www.unav.es/preventiva
1-yr within-group changes
in VIRGIN OLIVE OIL (VOO) consumption
3,5
*
3
Servings/d
2,5
2
1,5
1
*
0,5
0
VOO
DOG
Nuts
Control
www.unav.es/preventiva
1-yr within-group changes
in REFINED OLIVE OIL consumption
0,5
0
Servings/d
VOO
-1
-1,5
-2
DOG
Control
*
-0,5
-2,5
Nuts
*
www.unav.es/preventiva
1-yr within-group changes
TOTAL NUTS
1
*
Servings/d
0,8
0,6
0,4
0,2
*
0
VOO
-0,2
DOG
Nuts
Control
www.unav.es/preventiva
1-yr within-group changes
VEGETABLES
0,5
Servings/d
0,4
0,3
*
*
0,2
0,1
0
VOO
DOG
Nuts
Control
www.unav.es/preventiva
1-yr within-group changes
FRUITS
0,6
*
*
Servings/d
0,5
0,4
0,3
*
0,2
0,1
0
VOO
DOG
Nuts
Control
www.unav.es/preventiva
Servings/d
1-yr within-group changes
CEREALS
0,5
0,4
0,3
0,2
0,1
0
-0,1
-0,2
-0,3
-0,4
-0,5
DOG
VOO
*
Nuts
Control
*
Between-group: non-significant
www.unav.es/preventiva
Servings/d
1-yr within-group changes
LEGUMES
0,5
0,4
0,3
0,2
0,1
0
-0,1
-0,2
-0,3
-0,4
-0,5
DOG
*
*
VOO
Nuts
Control
www.unav.es/preventiva
1-yr within-group changes
FISH / SEAFOOD
0,5
0,4
0,3
Servings/d
0,2
0,1
0
-0,1
VOO
Nuts
Control
-0,2
-0,3
-0,4
-0,5
DOG
Between-group: non-significant
www.unav.es/preventiva
1-yr within-group changes
MEAT / MEAT PRODUCTS
0,5
0,4
0,3
Servings/d
0,2
0,1
0
-0,1
-0,2
VOO
Nuts
Control
*
*
*
-0,3
-0,4
-0,5
DOG
Between-group: non-significant
www.unav.es/preventiva
1-yr within-group changes
DAIRY
0,5
0,4
0,3
Servings/d
0,2
0,1
0
-0,1
VOO
Nuts
Control
-0,2
-0,3
-0,4
-0,5
DOG
Between-group: non-significant
www.unav.es/preventiva
1-yr within-group changes
ALCOHOL
0
VOO
-2
*
Nuts
*
Control
*
g/d
-4
-6
-8
Between-group: non-significant
-10
DOG
www.unav.es/preventiva
Baseline vs. 1-yr 14-unit Score
14
12
Units
10
11,2
10,8
9,0
8,9
Baseline
1-y follow-up
8,9
8,4
8
6
4
2
0
DOG
MeDiet+VOO
MeDiet+Nuts
Control
www.unav.es/preventiva
% Energy
1-yr within-group changes
Nutrient profile
DOG
3
2,5
2
1,5
1
0,5
0
-0,5
-1
-1,5
-2
-2,5
-3
*
*
*
VOO
Nuts
Control
*
*
*
Fat
CHO
Prot.
% Energy
www.unav.es/preventiva
DOG
15
12,5
10
7,5
5
2,5
0
-2,5
-5
-7,5
-10
-12,5
-15
Fat
CHO
Prot.
Intervention
Control
www.unav.es/preventiva
% Energy
1-yr within-group changes
Types of Fat
DOG
3
2,5
2
1,5
1
0,5
0
-0,5
-1
-1,5
-2
-2,5
-3
*
*
*
Nuts
VOO
*
*
Control
*
Between-group: non-significant for SFA
*
SFA
MUFA
PUFA
www.unav.es/preventiva
Urine tyrosol (μg/L): baseline vs. 1-yr
70
60
Baseline
1-y follow-up
55,4
50
41,7
40,3
40
30
20
10
0
VOO (n=127)
DOG
Nuts (n=115)
Control (n=102)
www.unav.es/preventiva
Plasma alpha-linolenic acid (%): baseline vs. 1-yr
70
61
60
50
Baseline
1-y follow-up
42
41
40
30
20
10
0
VOO (n=112)
DOG
Nuts (n=101)
Control (n=101)
www.unav.es/preventiva
Intervention vs. control
DOG
Significant between-group changes in food groups
VOO & nuts (+)
Vegetables (+)
Fruits (+)
Legumes (+)
14-unit MeDiet score (+)
Significant between-group changes in nutrient intake
Energy (+)
Carbohydrates (-)
Fiber (+)
Total fat (+)
MUFA, MUFA/SFA (+)
PUFA (+)
alpha-Linolenic acid (+)
Marine n-3 fatty acids (+)
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
1224 participants
409 VOO
411 Nuts
404 Control
Changes in the prevalence of MetS
ATP-III: 3 out of five
DOG
Waist
TG
HDL
Glucose
BP
www.unav.es/preventiva
DOG
www.unav.es/preventiva
PREDIMED TRIAL
•
•
•
•
•
•
•
•
•
DOG
Rationale
Funding sources
Methods and intervention protocol
Pilot study: Risk Factors at 3-mo (Ann Intern Med 2006)
Cross-sectional assessments:
o Diet & inflammatory markers (Eur J Clin Nutr 2007)
o MeDiet & risk factors (Eur J CV Prev 2008)
3-mo changes in oxLDL (Arch Intern Med 2008)
1-yr changes in diet (J Am Diet Assoc 2008)
1-yr changes in MetS (Arch Intern Med 2008)
Other nested sub-studies
www.unav.es/preventiva
Nested substudies
Main trial
DOG
1
2
3
4
5
6
7
...
n
www.unav.es/preventiva
DOG
www.unav.es/preventiva
www.predimed.es
www.unav.es/preventiva
Thank you
very much
DOG
www.unav.es/preventiva
DOG
www.unav.es/preventiva
de reserva
DOG
www.unav.es/preventiva
http://www.controlled-trials.com/ISRCTN35739639
Effects of Mediterranean diet on the primary
prevention of cardiovascular disease
DOG
www.unav.es/preventiva
http://www.controlled-trials.com/ISRCTN35739639
Effects of Mediterranean diet on the primary
prevention of cardiovascular disease
DOG
www.unav.es/preventiva
http://www.controlled-trials.com/ISRCTN35739639
Effects of Mediterranean diet on the primary
prevention of cardiovascular disease
DOG
www.unav.es/preventiva
Dietary changes at 1-yr & 2-yr follow-up
DOG
Nutrient
MD+VOO
MD+nuts
Control
Prot 1yr
2 yr
CHO 1yr
2 yr
Fat 1yr
2 yr
SFA 1yr
2 yr
-0.1
-0.6*
-1.3*
-1.4*
+1.8*
+2,6*
-0.6*
-0,6*
-0.3*
-0.5*
-2.1*
-0.7*
+2.7*
+1,5*
-0.7*
-0,8*
+0.1
+0.3
+1.0*
+2.5*
-1.0*
-2,5*
-0.4*
-1,0*
www.unav.es/preventiva
Dietary changes at 1-yr & 2-yr follow-up
DOG
Nutrient
MD+VOO
MD+nuts
Control
MUFA 1yr
2 yr
PUFA 1yr
2 yr
Fibre 1yr
2 yr
MD 1yr
14p 2 yr
+2.1*
+2.5*
+0.2
+0.7*
+2.2*
+2.9*
+1.9*
+2.4*
+1.6*
+1.8*
+1.8
+0.7*
+3.1*
+3.3*
+2.3*
+2.2*
-0.3
-1.0*
-0.3*
-0.4*
-0.5
-0.5
+0.5*
+0.8*
www.unav.es/preventiva
DOG
www.unav.es/preventiva
DOG
www.unav.es/preventiva
DOG
www.unav.es/preventiva
DOG
www.unav.es/preventiva
DOG
www.unav.es/preventiva
Power (asumming RR = 0,75)
1
0,9
0,8
0,7
0,6
0,5
0,4
0,3
0,2
0,1
0
600 580 560 540 520 500 480 460 440 420 400 380 360 340 320 300
DOG
Total # of events
(3 groups together)
www.unav.es/preventiva
The data from the
PREDIMED trial will be
analyzed at 5 intervals (4
interim analyses and the
final analysis).
The 4 interim analyses to
decide on the continuation
of the PREDIMED trial will
be conducted after 2, 3, 4
and 5 years of median
follow-up.
The 2-sided p-values for
stopping the trial at each
interim analysis are
DOG
Yr
Benefit Harm
2 08 5*10-6 9*10-5
Apr
3 09 0.001
Jun
0.005
4 10
Jul
0.02
0.009
5 11 0.02
Jun
0.05